PropertyValue
?:abstract
  • The global pandemic of severe acute respiratory syndrome coronavirus 2 has caused significant morbidity and mortality, not only causing devastating lung injury but also has an enormous effect on the cardiovascular system. The hypercoagulable state associated with coronavirus 2019 plays a major role in the disease manifestation. Venous thromboembolism including pulmonary embolism remains the most common thrombotic manifestation of the disease as compared to arterial thrombosis. Nonetheless, the co-occurrence of both venous and arterial thrombosis in a coronavirus 2019 patient, to our knowledge, has rarely been reported. Herein, we are presenting a case of co-occurrence of left ventricular thrombosis with pulmonary embolism in the setting of coronavirus 2019 with successful treatment with apixaban.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1177/2050313x20974534
?:journal
  • SAGE_Open_Med_Case_Rep
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/2c4a0948fba986ef4a617b4963ab9a3a6fc7e57f.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7675891.xml.json
?:pmcid
?:pmid
?:pmid
  • 33240504.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • A rare case of co-occurrence of pulmonary embolism and left ventricular thrombus in a patient with COVID-19
?:type
?:year
  • 2020-11-16

Metadata

Anon_0  
expand all